Patient-Controlled Analgesic To Serve As Interoperability Test Case
This article was originally published in The Gray Sheet
The Association for the Advancement of Medical Instrumentation plans to lead a project to test how the safety of interoperable medical devices could be evaluated.
You may also be interested in...
A patent-litigation settlement that Teva has reached with Ironwood and Allergan over Linzess will allow the Israeli firm to enter the US market with the linaclotide-based constipation treatment ahead of major rivals Mylan, Sandoz, Sun Pharma and Aurobindo.
Following Aspen’s admission last year that it was party to an illegal, anti-competitive agreement on fludrocortisone, Tiofarma has now also conceded to the UK’s Competition and Markets Authority that it took part in the deal.